AzTrials
AzTrials

OverweightPhase 1/2PONCT00807560

Parent-Based Treatment for Pediatric Overweight

A Phase 1/2 study testing FBT-PO and NEC in people with Overweight and Obesity, run by Icahn School of Medicine at Mount Sinai at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether a parent/guardian intervention for adolescent overweight/obesity more effective than a nutritional counseling education curriculum for reducing body mass index z-score (BMI Z-score) and related outcomes. Read more about this study

Who is it for?
Ages 13 to 17 years
Conditions the study is for
Overweight, Obesity
What is being tested?
FBT-PO and NEC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
77 participants
Where
2 sitesUnited States
Study dates
Sep 2008to Jun 2013
Phase
Phase 1/2
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Ages 13-17
  • Male and female
  • Living with at least one parent or guardian who is willing to participate in treatment
  • A BMI percentile >85% for gender and age (e.g., overweight or at risk for overweight)

Who cannot join

  • Current psychotic illness
  • Current alcohol/drug dependence
  • Active suicidality
  • Eating disorders (e.g., binge eating disorder)
  • History of bariatric surgery
  • Medication associated with significant weight changes (e.g., antipsychotics)
  • Serious medical or physical conditions resulting in significant weight changes (e.g., pregnancy, genetic disorders).
  • Complications of obesity that contraindicate moderate physical activity (e.g. orthopedic disorders)

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • The University of Chicago

    Chicago, Illinois, 60637

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029

Other trials in United States

About this study

The purpose of this study is to determine whether a parent/guardian intervention for adolescent overweight/obesity more effective than a nutritional counseling education curriculum for reducing body mass index z-score (BMI Z-score) and related outcomes.

Read the detailed description

Rates of pediatric overweight (PO) among Americans are increasing and associated with significant psychological, social, quality of life, and health related outcomes. Because of the broad mental and physical health implications of PO and the difficulty in sustaining weight loss as an adult, it is of interest to find successful methods of weight loss and/or prevention of weight gain for obese children and adolescents. The family unit is a logical and empirically supported point of intervention for PO. Interventions on this level have shown good long term efficacy in young children, but there is very little research on adolescent family intervention. Within the eating disorder literature, there is growing support for the efficacy of family-based interventions (FBI) for adolescents. Given its trans-developmental applicability, focus on family as the unit of intervention, and utility in creating a healthy eating environment, FBI is a logical candidate for adaptation to intervention for PO and intervention for at-risk for overweight youth (FBI-PO). The core of the current project is to test the feasibility and efficacy of an adapted FBI manual for adolescent overweight and at-risk for overweight in an outpatient eating and weight disorders clinic and compare this modality to a minimal nutritional educational control (NEC) condition.

Conditions
Overweight, Obesity
Being tested
FBT-PO, NEC
Keywords
Overweight, Obesity, Adolescents, Family Therapy
Medical subject headings
Overweight, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FBT-POBehavioural

    Also called Family Based Therapy for Pediatric Overweight

    The goal of FBT-PO is to resolve the eating disorder and return the patient to healthy psychosocial and physiological developmental trajectories through active family involvement across three treatment phases.

  • NECBehavioural

    Also called Nutritional Educational Control Condition

    Families assigned to NEC will receive a minimal nutrition and physical activity education curriculum across 16 sessions over 24 weeks.

Study groups in NCT00807560
Study groupRoleWhat they receive
FBT-POExperimentalFamily Based Therapy for Pediatric Overweight.
Receives: Behavioral: FBT-PO
NEC-controlActive comparatorNutritional Educational Control Condition (NEC).
Receives: Behavioral: NEC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BMI Z Score

    Z-score was calculated using the Baylor College of Medicine Children's Nutrition Research Center's online BMI calculator (https://www.bcm.edu/research/centers/childrens-nutrition-research-center/bodycomp/bmiz2.html).

    Measured: baseline

  2. BMI Z Score

    Z-score was calculated using the Baylor College of Medicine Children's Nutrition Research Center's online BMI calculator (https://www.bcm.edu/research/centers/childrens-nutrition-research-center/bodycomp/bmiz2.html)

    Measured: up to 44 weeks

Secondary outcomes (13)
  1. Percent Completion

    Percent of participants who completed the trial to assess feasibility and retention in the trial

    Measured: at 44 weeks

  2. Waist Measurement

    Waist measurement in inches. This is not a primary outcome variable.

    Measured: baseline

  3. Waist Measurement

    Waist measurement in inches. This is not a primary outcome variable.

    Measured: up to 44 weeks

  4. Hip Measurement

    Hip measurement in inches. This is not a primary outcome variable.

    Measured: baseline

  5. Hip Measurement

    Hip measurement in inches. This is not a primary outcome variable.

    Measured: up to 44 weeks

  6. Height

    This variable informs the calculation of the outcome variable of BMI Z score.

    Measured: Baseline

  7. Height

    This variable informs the calculation of the outcome variable of BMI Z score.

    Measured: up to 44 weeks

  8. Weight

    This variable informs the calculation for the outcome variable of BMI Z score.

    Measured: baseline

  9. Weight

    This variable informs the calculation of the outcome variable of BMI z score.

    Measured: up to 44 weeks

  10. BMI

    Body Mass Index: this variable informs the calculation of the outcome variable of BMI z-score.

    Measured: baseline

  11. BMI

    Body Mass Index: this variable informs the calculation of the primary outcome variable of BMI z-score.

    Measured: up to 44 weeks

  12. BMI Percentile

    Body Mass Index percentile. This is not a primary outcome variable.

    Measured: baseline

  13. BMI Percentile

    Body Mass Index percentile. This is not a primary outcome variable.

    Measured: up to 44 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2008 (estimated)
  2. Study startSep 2008
  3. Primary completionJun 2013
  4. Study completionJun 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00807560
Sponsor's protocol ID
GCO 07-0216
Other IDs
1R21HD057394-01
Acronym
PO
Status last verified
Dec 2015
First submitted
11 Dec 2008
Last updated
8 Jan 2016
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing FBT-PO and NEC in people with Overweight and Obesity, run by Icahn School of Medicine at Mount Sinai at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 8 Jan 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BMI Z Score (time frame: baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Parent-Based Treatment for Pediatric Overweight | AzTrials